Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Antares Pharma Inc (ATRS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Antares's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Antares historical data, for real-time data please try another search
5.590 0.000    0.00%
23/05 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 5.580 - 5.600
Antares 5.590 0.000 0.00%

Antares Pharma Inc Company Profile

 
Get an in-depth profile of Antares Pharma Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

202

Equity Type

ORD

Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in targeted therapeutic areas. It develops, manufactures, and commercializes novel therapeutic products using its drug delivery systems. The company’s injection products include XYOSTED for subcutaneous administration of testosterone replacement therapy in adult males; OTREXUP a subcutaneous methotrexate injection indicated for adults with severe active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis, and adults with severe recalcitrant psoriasis; and NOCDURNA sublingual tablets indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least two times per night to urinate. Its injection products also comprise generic Epinephrine Injection USP products indicated for emergency treatment of severe allergic reactions, including anaphylaxis in adults and certain pediatric patients; Sumatriptan Injection USP indicated for the acute treatment of migraine headaches and cluster headache in adults; and Makena subcutaneous auto-injector drug-device combination product indicated to reduce the risk of preterm birth in women, as well as Teriparatide injection used for the treatment of osteoporosis in postmenopausal women and men at increased risk of fracture, and glucocorticoid induced osteoporosis in men and women. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; QuickShot auto-injectors; TLANDO to treat deficiency or absence of endogenous testosterone in adult males; and drug/device products for urologic oncology, immunology, and endocrinology. The company has strategic alliances and partnerships with Pfizer Inc., Idorsia Pharmaceuticals Ltd, Teva Pharmaceutical Industries, Ltd, and AMAG. Antares Pharma, Inc. was incorporated in 1979 and is headquartered in Ewing, New Jersey. As of May 23, 2022, Antares Pharma, Inc. operates as a subsidiary of Halozyme Therapeutics, Inc.

Contact Information

Address 100 Princeton South Suite 300
Ewing, 08628
United States
Phone 609 359 3020
Fax -
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ATRS Comments

Write your thoughts about Antares Pharma Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Robert Brastrom
Robert Brastrom Jan 22, 2022 12:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock is looking good to enter soon!
Nguyen Anh
Nguyen Anh Nov 14, 2021 7:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is it good ?
NY Brokers Stock Exchange
NY Brokers Stock Exchange Aug 12, 2021 5:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i am back .
Rodo Sobarzo
Rodo Sobarzo Apr 22, 2021 10:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why this stock hasnt gone up after the last ER is a mystery to me... well, let's keep buying at this bargain price
Carlos Andres
Carlos Andres Dec 14, 2020 3:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
next level: 4.20
FARORISHON fr
FARORISHON fr Dec 14, 2020 3:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
you got it right !
FARORISHON fr
FARORISHON fr Dec 14, 2020 3:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
you got it right !
Viktor Hegedus
Viktor Hegedus Dec 14, 2020 3:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What˘s the news? :-)
Carlos Andres
Carlos Andres Dec 09, 2020 10:23AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
time to buy
Ian King
Ian King Nov 12, 2019 6:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
antare pharma inc ? you think is a good stock to invest ? best regards, Ian King from Bulgaria.
will hicks
will hicks Aug 13, 2019 9:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
overpriced garbage
Brandon Currier
Brandon Currier Aug 13, 2019 9:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Poor bear, RIP
Ian King
Ian King Aug 13, 2019 9:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hello Mr. Hicks, do you think is a good case to buy now Antares ?
Brandon Currier
Brandon Currier Aug 13, 2019 9:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Wow you sure did a good job with your speculation. Lol
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email